38 related articles for article (PubMed ID: 24291039)
1. Preventing the autophagic survival response by inhibition of calpain enhances the cytotoxic activity of bortezomib in vitro and in vivo.
Escalante AM; McGrath RT; Karolak MR; Dorr RT; Lynch RM; Landowski TH
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1567-76. PubMed ID: 23572175
[TBL] [Abstract][Full Text] [Related]
2. A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma.
Chauhan D; Singh AV; Aujay M; Kirk CJ; Bandi M; Ciccarelli B; Raje N; Richardson P; Anderson KC
Blood; 2010 Dec; 116(23):4906-15. PubMed ID: 20805366
[TBL] [Abstract][Full Text] [Related]
3. A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.
Peltonen K; Colis L; Liu H; Trivedi R; Moubarek MS; Moore HM; Bai B; Rudek MA; Bieberich CJ; Laiho M
Cancer Cell; 2014 Jan; 25(1):77-90. PubMed ID: 24434211
[TBL] [Abstract][Full Text] [Related]
4. Natural gambogic acid-tuned self-assembly of nanodrugs towards synergistic chemophototherapy against breast cancer.
Lin B; Peng X; Cheng J; Wang J
J Mater Chem B; 2024 May; ():. PubMed ID: 38804636
[TBL] [Abstract][Full Text] [Related]
5. Plant-derived natural products and combination therapy in liver cancer.
Wang Y; Li J; Xia L
Front Oncol; 2023; 13():1116532. PubMed ID: 36865794
[TBL] [Abstract][Full Text] [Related]
6. Polyphenols: Chemoprevention and therapeutic potentials in hematological malignancies.
Izuegbuna OO
Front Nutr; 2022; 9():1008893. PubMed ID: 36386899
[TBL] [Abstract][Full Text] [Related]
7. Multiple Myeloma Inhibitory Activity of Plant Natural Products.
Jöhrer K; Ҫiҫek SS
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072312
[TBL] [Abstract][Full Text] [Related]
8. Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment.
Ma Z; Fan Y; Wu Y; Kebebe D; Zhang B; Lu P; Pi J; Liu Z
Int J Nanomedicine; 2019; 14():2029-2053. PubMed ID: 30962686
[TBL] [Abstract][Full Text] [Related]
9. Potential Anticancer Agents Characterized from Selected Tropical Plants.
Ren Y; de Blanco EJC; Fuchs JR; Soejarto DD; Burdette JE; Swanson SM; Kinghorn AD
J Nat Prod; 2019 Mar; 82(3):657-679. PubMed ID: 30830783
[TBL] [Abstract][Full Text] [Related]
10. Gambogic acid triggers vacuolization-associated cell death in cancer cells via disruption of thiol proteostasis.
Seo MJ; Lee DM; Kim IY; Lee D; Choi MK; Lee JY; Park SS; Jeong SY; Choi EK; Choi KS
Cell Death Dis; 2019 Feb; 10(3):187. PubMed ID: 30796201
[TBL] [Abstract][Full Text] [Related]
11. Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer.
Xia X; Liao Y; Guo Z; Li Y; Jiang L; Zhang F; Huang C; Liu Y; Wang X; Liu N; Liu J; Huang H
Oncogenesis; 2018 Sep; 7(9):75. PubMed ID: 30250021
[TBL] [Abstract][Full Text] [Related]
12. The harsh microenvironment in infarcted heart accelerates transplanted bone marrow mesenchymal stem cells injury: the role of injured cardiomyocytes-derived exosomes.
Hu M; Guo G; Huang Q; Cheng C; Xu R; Li A; Liu N; Liu S
Cell Death Dis; 2018 Mar; 9(3):357. PubMed ID: 29500342
[TBL] [Abstract][Full Text] [Related]
13. Molecular targets of gambogic acid in cancer: recent trends and advancements.
Kashyap D; Mondal R; Tuli HS; Kumar G; Sharma AK
Tumour Biol; 2016 Oct; 37(10):12915-12925. PubMed ID: 27448303
[TBL] [Abstract][Full Text] [Related]
14. Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe3O4 magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells.
Zhang W; Qiao L; Wang X; Senthilkumar R; Wang F; Chen B
Int J Nanomedicine; 2015; 10():3275-89. PubMed ID: 25995634
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induction associated with the ER stress response through up-regulation of JNK in HeLa cells by gambogic acid.
Krajarng A; Imoto M; Tashiro E; Fujimaki T; Shinjo S; Watanapokasin R
BMC Complement Altern Med; 2015 Feb; 15():26. PubMed ID: 25887496
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells.
Vogel RI; Coughlin K; Scotti A; Iizuka Y; Anchoori R; Roden RB; Marastoni M; Bazzaro M
Oncotarget; 2015 Feb; 6(6):4159-70. PubMed ID: 25784654
[TBL] [Abstract][Full Text] [Related]
17. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo.
Liu N; Huang H; Xu L; Hua X; Li X; Liu S; Yang C; Zhao C; Zhao C; Li S; Dou QP; Liu J
Toxicol Lett; 2014 Jan; 224(3):333-40. PubMed ID: 24291039
[TBL] [Abstract][Full Text] [Related]
18. HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo.
Huang H; Liu N; Yang C; Liao S; Guo H; Zhao K; Li X; Liu S; Guan L; Liu C; Xu L; Zhang C; Song W; Li B; Tang P; Dou QP; Liu J
PLoS One; 2012; 7(12):e52576. PubMed ID: 23285100
[TBL] [Abstract][Full Text] [Related]
19. Gambogic acid enhances proteasome inhibitor-induced anticancer activity.
Huang H; Chen D; Li S; Li X; Liu N; Lu X; Liu S; Zhao K; Zhao C; Guo H; Yang C; Zhou P; Dong X; Zhang C; Guanmei ; Dou QP; Liu J
Cancer Lett; 2011 Feb; 301(2):221-8. PubMed ID: 21216092
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
